Clinical manifestations include using OPN as a biomarker for infections, lymphoma, primary aPL syndrome, early rheumatoid arthritis, autoimmune thyroiditis, autoimmune hepatitis, interstitial lung disease, and fibromyalgia [71]. This evidence concerns the gene SPP1 and interstitial lung disease.